Literature DB >> 7551047

Unusual effect of myo-inositol on phospholipid biosynthesis in Cryptococcus neoformans.

Vicki L Vincent, Lisa S Klig.   

Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen which preferentially localizes to the inositol-rich environment of the central nervous system. One of its distinguishing traits is its capacity to catabolize inositol. Inositol is a precursor for the synthesis of phosphatidylinositol (PI). This study demonstrated that C. neoformans synthesizes inositol. Three inositol-containing sphingolipids were identified in C. neoformans: ceramide-(P-inositol)2mannose, mannose, ceramide-P-inositol-mannose, and ceramide-P-inositol. These inositol-containing sphingolipids are typical of fungi but not higher eukaryotes. The effect of inositol on the membrane lipid composition of C. neoformans was also examined. In contrast to the nonpathogenic yeast Saccharomyces cerevisiae, neither the PI composition nor the synthesis of methylated phospholipids was altered by exogenous inositol. Hence, C. neoformans appears to have a metabolic mechanism for maintaining a steady lipid composition regardless of the inositol in its environment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551047     DOI: 10.1099/13500872-141-8-1829

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

1.  Isolation and composition of inositolphosphorylceramide-type sphingolipids of hyphal forms of Candida albicans.

Authors:  G B Wells; R C Dickson; R L Lester
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

2.  Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth.

Authors:  M L Rodrigues; L R Travassos; K R Miranda; A J Franzen; S Rozental; W de Souza; C S Alviano; E Barreto-Bergter
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Two major inositol transporters and their role in cryptococcal virulence.

Authors:  Yina Wang; Tong-bao Liu; Guillaume Delmas; Steven Park; David Perlin; Chaoyang Xue
Journal:  Eukaryot Cell       Date:  2011-03-11

Review 4.  Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action.

Authors:  M E Cardenas; M C Cruz; M Del Poeta; N Chung; J R Perfect; J Heitman
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

5.  Role of an expanded inositol transporter repertoire in Cryptococcus neoformans sexual reproduction and virulence.

Authors:  Chaoyang Xue; Tongbao Liu; Lydia Chen; Wenjun Li; Iris Liu; James W Kronstad; Andreas Seyfang; Joseph Heitman
Journal:  MBio       Date:  2010-05-18       Impact factor: 7.867

6.  Cryptococcus neoformans UGT1 encodes a UDP-Galactose/UDP-GalNAc transporter.

Authors:  Lucy X Li; Angel Ashikov; Hong Liu; Cara L Griffith; Hans Bakker; Tamara L Doering
Journal:  Glycobiology       Date:  2016-08-03       Impact factor: 4.313

7.  Temperature-regulated transcription in the pathogenic fungus Cryptococcus neoformans.

Authors:  Barbara R Steen; Tian Lian; Scott Zuyderduyn; William Kim MacDonald; Marco Marra; Steven J M Jones; James W Kronstad
Journal:  Genome Res       Date:  2002-09       Impact factor: 9.043

Review 8.  Environmental Factors That Contribute to the Maintenance of Cryptococcus neoformans Pathogenesis.

Authors:  Maphori Maliehe; Mathope A Ntoi; Shayanki Lahiri; Olufemi S Folorunso; Adepemi O Ogundeji; Carolina H Pohl; Olihile M Sebolai
Journal:  Microorganisms       Date:  2020-01-28

9.  Brain inositol is a novel stimulator for promoting Cryptococcus penetration of the blood-brain barrier.

Authors:  Tong-Bao Liu; Jong-Chul Kim; Yina Wang; Dena L Toffaletti; Eliseo Eugenin; John R Perfect; Kee Jun Kim; Chaoyang Xue
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

10.  The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a sphingolipid dependent manner.

Authors:  Rasmus Bojsen; Rasmus Torbensen; Camilla Eggert Larsen; Anders Folkesson; Birgitte Regenberg
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.